Health News Releases

  • Today May 18
May 03, 2018 13:55
Boston Healthcare Adds Seasoned Market Access Leader to Global Life Science Consulting Team
Boston Healthcare Associates Inc. (Boston Healthcare), a global life sciences consulting firm, today announced that Mark Girardi has joined the firm as Vice President to further develop a growing nati
ZOLL AED Plus
May 03, 2018 09:55
ZOLL Awarded Singapore’s Save-A-Life Initiative to Install 5,000 AED Plus Units in Public Housing
ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that it has been awarded the Singapore Save-A-Life (SAL) initi
April 26, 2018 11:45
Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries
Family-owned pharmaceutical company Boehringer Ingelheim today presented its latest pipeline updates at a Research & Development press conference entitled ‘Transcending Disease Boundaries’, at its glo
April 25, 2018 16:15
Sixteen Healthcare Groups Make Major Commitments at 2nd Annual Patient Safety Rally in Taiwan
The Patient Safety Movement Foundation (PSMF) joined the Taiwan Patient Safety Culture Club (TPSCC) at the 2nd Annual Patient Safety Rally hosted by the TPSCC in Taichung, Taiwan on April 21, 2018. Si
April 25, 2018 11:20
New Analyses from Pivotal Phase III Trials of Oral Ozanimod in Relapsing Multiple Sclerosis To Be Presented at the 2018 American Academy of Neurology Annual Meeting
Celgene Corporation (NASDAQ:CELG) today announced additional phase III data analyses evaluating the efficacy and safety of ozanimod, a novel, oral, selective sphingosine 1-phosphate 1 (S1P1) and 5 (S1
April 24, 2018 19:40
HitGen Announces Research Collaboration and License Agreement with Simcere
Simcere Pharmaceutical Group (Simcere) and HitGen Ltd (HitGen) announced today that they have entered into a license agreement on innovative drug discovery. Based on the multi-year research collabo
April 20, 2018 17:35
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA)
April 18, 2018 09:00
Twist Bioscience Accelerates Global Expansion with Strategic Asia Pacific Distribution Agreements
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that the company has expanded its presence in Asia Pacific, ad
April 17, 2018 13:45
The Health Industry Summit (tHIS) to Play a Greater Role as China Set to Boost Health Industry for a Higher Level of National Health Care
The Health Industry Summit (tHIS) 2018 hosted by Reed Sinopharm, opened in Shanghai at the National Exhibition and Convention Center on 11 April 2018. This is the largest gathering of healthcare indus
April 17, 2018 11:15
Boehringer Ingelheim and Lilly Announce an Academic Collaboration with University of Oxford to Investigate the Effects of Empagliflozin in People with Chronic Kidney Disease
Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced an academic collaboration with the University of Oxford. EMPA-KIDNEY will investigate the effects of empagliflozin on the prog
April 16, 2018 12:00
Patient Safety Movement Foundation Supports the Tokyo Declaration on Patient Safety
The Patient Safety Movement Foundation (PSMF) announced its support for the Tokyo Declaration on Patient Safety, which was put forward by Japan, Germany, and the United Kingdom at the Third Global Min
April 12, 2018 09:45
Boehringer Ingelheim to invest €65 million in avian vaccines
Six months after inaugurating its new French animal health headquarters in the heart of the Lyon-Gerland Biodistrict, Boehringer Ingelheim has confirmed its allegiance to the region by announcing that
April 11, 2018 18:10
HeartSciences Announces Publication of Clinical Study Results in the Journal of the American College of Cardiology (JACC)
HeartSciences, a medical device company leading innovation in electrocardiography through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence, announced
April 11, 2018 12:00
JPT Peptide Technologies Launches The Human Proteome Peptide Catalog
JPT Peptide Technologies (JPT) announces the launch of The Human Proteome Peptide Catalog, the first and most comprehensive online resource for validated reference peptides in mass-spectrometry based
April 10, 2018 19:20
Swiss Advanced Vision Launches Active Intraocular Lens Concept with Real-Time Autofocus for Cataract Surgery
Swiss Advanced Vision (SAV-IOL) has announced the launch of Project R-TASC, set to disrupt the global intraocular lens (IOL) market. Cataracts are responsible for 51% of world blindness, which repr
April 10, 2018 16:55
HeartSciences Showcases MyoVista® Wavelet ECG at 2018 China International Medicinal Equipment Fair (CMEF)
HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 China International Medicinal Equipment Fair (CMEF) Shanghai, China, Ap
April 06, 2018 09:40
Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.
Ferring Pharmaceuticals* and Rebiotix Inc. today announce that they have agreed to the acquisition of Rebiotix by Ferring. This acquisition brings together two innovative healthcare companies that sha
April 05, 2018 13:15
Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors
Boehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, today announced a collaboration and exclusive worldwide collaboration
April 04, 2018 14:25
Impossible Foods Announces $114 Million Convertible Note as Startup Prepares for Rapid Expansion in the US and Overseas
Impossible Foods announced today the successful closing of about $114 million in convertible note financing. The food technology startup has raised approximately $214 million in the past 18 months
April 03, 2018 13:10
ResMed Hires Bobby Ghoshal as First Chief Technology Officer
ResMed (NYSE: RMD, ASX: RMD) today announced the hire of its first chief technology officer (CTO), Bobby Ghoshal, effective today. As CTO, Ghoshal will lead ResMed’s global healthcare informatics a
April 02, 2018 15:00
PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme
PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announced today that U.S. Food and Drug Administration (FDA) has granted orph
March 30, 2018 14:25
Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine[1]
Boehringer Ingelheim today announced data from the landmark 52-week DYNAGITO® trial which show that in people with COPD (chronic obstructive pulmonary disease), Spiolto® Respimat® (tiotropium/olodater
March 30, 2018 11:50
Toshiba Heavy-Ion Therapy System Awarded by Yonsei University Health System
Toshiba Energy Systems & Solutions Corporation (Toshiba ESS), a world leader in heavy-ion therapy system, in collaboration as a consortium with DK Medical Solutions, a Korean leading global medical co
March 27, 2018 09:55
Three Leading Animal Health Companies Join Hands to Launch World-Class Vaccine Joint Venture Targeting Foot-and-Mouth Disease in China
Shaanxi Meili Omni-Honesty Animal Health Co., Ltd., China’s world-class vaccine company targeting foot-and-mouth disease in swine, was launched on March 24th with a groundbreaking ceremony held at the
March 26, 2018 15:30
Takeda Announces Publication of Final Data from ICLUSIG® (ponatinib) Pivotal Phase 2 PACE Trial in Blood
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that final data from the pivotal Phase 2 PACE clinical trial of ICLUSIG (ponatinib) in refractory chronic myeloid leukemia (CML) or Ph
25 per page50 per page75 per page100 per page